Global Omega Balance Open Letter

A Global Call for Scientific Attention to Essential Fatty Acid Balance

Scientists, clinicians and researchers from around the world are calling for greater attention to the balance of omega-3 and omega-6 fatty acids in the modern food supply and their relationship to human health.

Truth in Health Association is helping bring these voices together through an open scientific statement calling for continued research, professional education, public awareness and coordinated scientific review.

Why This Matters

The Composition of Our Food Has Changed.

Omega-3 and omega-6 fatty acids are both essential nutrients, but changes in agriculture, food processing, animal feeds and dietary patterns have altered the fatty acid composition of the modern food supply.

Researchers continue to investigate what those changes mean for inflammation, metabolism, neurological development, cardiovascular health, the endocannabinoid system and other areas of human physiology. The purpose of this initiative is to encourage rigorous scientific attention to those questions.

This Is a Call for Investigation — Not a Simplistic Dietary Prescription.

The scientific statement recognizes areas of established knowledge as well as questions that remain under active scientific discussion. Its purpose is not to label a single nutrient as good or bad, but to encourage transparent assessment of how modern dietary patterns and food systems may influence essential fatty acid exposure and human biology.

Scientific Community

Continue investigating essential fatty acid exposure, biomarkers, biological effects and health outcomes.

Health Professionals

Strengthen professional education and awareness around essential fatty acids and their physiological roles.

Public Institutions

Support transparent scientific review, better data and evidence-informed public-health discussion.

Read. Review. Participate.

Read the Scientific Statement

Review the statement, explore the scientific considerations and see the researchers and clinicians who have added their names to the initiative.

Read the Statement ↓ 

 

Scientific Statement

Global Scientific Statement on Essential Fatty Acids, Lipid Composition, and Human Health

To Heads of State, Ministers of Health, Directors of International and Regional Health Agencies, and Leaders of Global Food and Agriculture Systems:

We, the undersigned scientists and clinicians working in lipid biology, nutrition, metabolism, developmental neuroscience, resolution pharmacology, and the endocannabinoid system, write to draw your attention to a critical but addressable aspect of modern human nutrition: the altered intake and biological handling of essential fatty acids, particularly omega-3 and omega-6 polyunsaturated fatty acids (PUFAs), and their impact on human physiology across the life course.

Our aim is not to declare a simple “villain” nutrient, but to underscore that current dietary patterns and food systems have created a biochemical milieu without historical precedent, and that this milieu may have important implications for inflammation, neurodevelopment, cardiometabolic disease, and healthy aging. We believe this warrants coordinated national and international assessment, guidance, and education.

Established Foundations

Essential Fatty Acids: What Is Not in Dispute

There is broad scientific agreement that:

  1. Omega-3 and omega-6 fatty acids are both essential.
    They are required for membrane structure, cell signaling, neurodevelopment, immune function, and the production of a wide range of lipid mediators, including eicosanoids and specialized pro-resolving mediators (SPMs).
  2. Individual fatty acids are not interchangeable.
    Linoleic acid (LA), arachidonic acid (ARA), gamma-linolenic acid (GLA), dihomo-gamma-linolenic acid (DGLA), eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and docosapentaenoic acid (DPA) each have distinct structures, metabolic fates, and biological effects. Treating “omega-6” or “omega-3” as homogeneous categories can obscure important differences in risk and benefit.
  3. Requirements change across the lifespan.
    For example, arachidonic acid and DHA are especially critical during fetal development and early childhood for proper brain, eye, and immune development, and inadequacy in these windows can have lifelong consequences.
  4. Modern dietary patterns differ substantially from those in which human physiology evolved.
    Agricultural practices, animal feed composition, food processing, and global supply chains have altered the fatty acid composition of both plant oils and animal-source foods, often increasing certain omega-6 species and reducing long-chain omega-3s.
  5. Many human populations studied today are not nutritionally “ideal.”
    Evidence suggests that current reference ranges may reflect populations with altered fatty-acid profiles, micronutrient insufficiencies, and chronic low-grade inflammation.

Why This Matters for Public Health and National Capacity

Essential fatty acids participate in:

  • regulation of inflammation and its resolution,
  • brain development, cognition, and mental health,
  • cardiovascular and metabolic homeostasis,
  • immune competence and host defense,
  • the function of systems such as the endocannabinoid system.

When intake patterns and tissue composition of these fatty acids are substantially shifted—whether by high LA intake, low EPA/DHA intake, altered animal feeds, or ultra-processed dietary patterns—there is concern that inflammatory responses, neurodevelopmental trajectories, and cardiometabolic risk profiles may be negatively affected.

These issues affect educational attainment, workforce productivity, and long-term health expenditure trajectories of every nation.

Scientific Transparency

Areas of Active Scientific Discussion

The undersigned acknowledge ongoing scientific debate, including:

  • Individual omega-6 fatty acids behave differently and should not be grouped into a single category.
  • The meaning and usefulness of a single “omega-6:omega-3 ratio” without specifying fatty acids, tissues, or context.
  • Age-dependent requirements and windows of vulnerability (pregnancy, early childhood, aging).

These open questions strengthen rather than weaken the case for coordinated action. They highlight how much is at stake and how much clarity is still needed.

Recommended Action

What We Urge Governments and International Bodies to Do

1. Establish National Essential Fatty Acid Committees or Task Forces

Mandated to review current intakes, tissue levels, and health outcomes related to key fatty acids, with representation from lipid biochemistry, clinical nutrition, pediatrics, neurology, psychiatry, cardiometabolism, immunology, and public health.

2. Conduct Comprehensive National and Regional Assessments

Map dietary intakes; assess biomarkers; evaluate associations with cardiovascular disease, diabetes, obesity, autoimmune and inflammatory conditions, neurodevelopmental and neurodegenerative disorders, and mental health.

3. Develop Evidence-Based Guidance for Food Systems and Agriculture

Review how agricultural policies, animal feeds, and food processing affect population exposures to specific fatty acids; consider improvements for long-chain omega-3 intake.

4. Integrate Essential Fatty Acids into Health Professional Education

Ensure medical, nursing, dietetic, and public-health training includes robust coverage of fatty acids and their physiological roles.

5. Support Research on Individual Fatty Acids and Lifespan Needs

Fund mechanistic and clinical research; clarify age-specific requirements; improve methods for tissue-level lipid assessment.

6. Collaborate Through International Platforms

Utilize WHO, FAO, UNICEF, and other agencies to harmonize data and develop guidance.

A Call for Leadership

A Call for Coordinated, Evidence-Based Leadership

This statement is not a call for simplistic dietary prescriptions or for blaming any single nutrient. It is a call for recognition that modern fatty acid patterns differ substantially from those that shaped human physiology; for transparent assessment of their relationship to disease burden and human potential; and for leadership in aligning agriculture, food policy, and health systems with biological needs.

The potential gains in health, cognition, resilience, and national prosperity could be generational.

Respectfully,

Charles “Chip” Paul

ECS Theorist & Public Health Advocate
Convenor, Global Scientific Statement on Essential Fatty Acids,
Lipid Composition & Human Health


Scientific Signatories

Prof. Philip C. Calder, PhD, RNutr, FSB, FAfN
Professor of Nutritional Immunology
Faculty of Medicine
University of Southampton
Southampton, United Kingdom

Hagler Fellow
College of Medicine
Texas A&M University
College Station, Texas, USA

Prof. Michael A. Crawford, PhD, FRSB, FRSC, FRCPath
Visiting Professor, Department of Metabolism, Digestion and Reproduction
Chelsea & Westminster Hospital Campus
Imperial College London
United Kingdom

Prof. Jesmond Dalli, PhD, FHEA, FRSB, FBPhS
Professor of Molecular Pharmacology
Director, Lipid Mediator Unit
William Harvey Research Institute
Barts and The London School of Medicine and Dentistry
Queen Mary University of London
United Kingdom

Prof. Vincenzo Di Marzo, PhD
Canada Excellence Research Chair, Microbiome–Endocannabinoidome Axis in Metabolic Health
Université Laval, Quebec, Canada
Research Director, Institute of Biomolecular Chemistry
Consiglio Nazionale delle Ricerche (CNR), Italy

Prof. Jörg (Jürg) Gertsch, PhD
Professor, Institute of Biochemistry and Molecular Medicine
University of Bern
Switzerland

Prof. William S. Harris, PhD
Founder and President, Fatty Acid Research Institute
Professor of Medicine (Emeritus), Sanford School of Medicine
University of South Dakota
United States

Prof. Daniele Piomelli, PhD, MD (h.c.)
Distinguished Professor of Anatomy & Neurobiology, Biological Chemistry, and Pharmaceutical Sciences
Louise Turner Arnold Chair in the Neurosciences
Director, Center for the Study of Cannabis
University of California, Irvine
United States

Adjunct Professor
University of Vienna
Austria

Prof. Charles N. Serhan, PhD, DSc
Gelman Professor of Anaesthesia (Biochemistry & Molecular Pharmacology)
Director, Center for Experimental Therapeutics and Reperfusion Injury
Brigham and Women’s Hospital
Harvard Medical School
United States

Prof. Clemens von Schacky, MD
Chief Executive Officer, Omegametrix GmbH
Senior Researcher in Preventive Cardiology and Lipidomics
Munich, Germany

SIGN THE OPEN LETTER